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Summary.-The radiosensitizing effect of iodoacetamide was studied in a C3H
mouse mammary carcinoma together with its toxicity to the host. TCD50 or radia-
tion dose to yield 50% tumour control frequency was determined in tumours treated
or untreated with the agent. Results indicated that 15 mg/kg of iodoacetamide
sensitized hypoxic tumour cells, as did atmospheric oxygen, and the sensitization
was not detectable below this dose. Experiments with fractionated treatments
suggested that the reoxygenation occurring during the treatment intervals of 24
hours might be more important in the sterilization of tumour cells than the agent.
IT has been demonstrated that iodo-
acetamide (IA), one of the thiol-binding
agents, enhanced the response to ionizing
radiation of bacteria, particularly radio-
resistant bacteria (Dean and Alexander,
1962) and of mammalian cells (Bianchi
et al., 1964). Some short-lived transients
of IA formed after irradiation were
considered to be responsible for this effect
(Dewey and Michael, 1965; Mullenger
et al., 1967). In this communication, the
sensitizing effect of the agent to tumours
was studied. The aim was to investigate
how large a population ofhypoxic tumour
cells, which are the critical cells in
radiotherapy, could be sensitized by the
agent.
MATERIALS AND METHODS
Animal-tumour system.-C3H/He mice of
both sexes were supplied by Funabashi Farm
Co., Chiba. They were kept in small animal
units in our Department and provided with
purina pellets and water ad libitum. Third
generation isotransplants derived from a
single spontaneous C3H/He mouse mammary
carcinoma were used in all the experiments.
The spontaneous and first generation tumours
were stored in liquid nitrogen and first
generation tumours were transplanted into
subcutaneous tissue of several female mice
for experimental use as needed.
Preparation of single cell suspension.-
Animals carrying second generation tumours
were sacrificed by cervical dislocation and
tumours were excised. Intact tumour tissue
was minced finely with scissors and suspended
in Hank's medium containing 5% foetal calf
serum. The mince was sedimented in test
tubes stood in crushed ice for 20 min. The
supernatant was removed by syringe and
passed through a swinny filter, and then
centrifuged for 5 min. The sediment was
resuspended with a small amount of Hank's
medium and served for transplantation.
Viable tumour cells were counted in a
haemacytometer by use of the trypan-blue
staining method.
Tumour irradiation.-An x-ray machine
was operated at 180 kVp and 25 mA with
a filter of 2 mm Al. Half value layer
was 8-0 mm Al, target tumour distance was
19 cm. Dose rate at the tumour centre was
660 rad/min (Urano, Tanaka and Hayashi,
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1972). In order to obtain homogeneous
dose distribution, animals were rotated
halfway through the irradiation period.
Local hypoxia was obtained by applying a
heavy brass clamp above the tumour, while
for air irradiation the tumours were irradiated
when the animals were breathing normal air.
For oxygenated irradiation ofthe tumour the
animals were breathing 500 CO2 + 950O02 in
a small plastic chamber. The animals were
anaesthetized by intraperitoneal injection
of Nembutal before irradiation.
Whole body irradiation.-Physical factors
were: 180 kVp, 25 mA, 07 mm Cu of HVL
and TSD 55 cm. Twelve animals, kept in
a round plastic cage with 12 centripetal
individual compartments, were irradiated
simultaneously. The cage was set on a
rotating table to distribute a constant dose.
The dose rate in the centre of each mouse
was 70 rad/min.
Experimental assay methods.-Three
methods were employed, and a brief descrip-
tion ofthese is given below:
(a) The radiation dose to yield local
control in 5000 of the irradiated tumours
(TCD50) was found and used as the baseline
in experiments to examine the sensitizing
effect of the test materials on the tumours.
Tumours were irradiated when they reached
8 mm in average diameter or 250 mm3.
After irradiation, the animals were checked
once a week for possible tumour recurrence
for a period of 120 days (Urano et al., 1972).
(b) The determination of the number of
viable tumour cells expected to give rise to
a tumour in half of the recipients (TD50),
was applied for experiments to test the
cytotoxicity of the agent. The single cell
suspension was admixed with the isologous
tumour cells which had been irradiated
lethally with 10,000 rad, in a ratio of 1: 103.
This suspension was serially diluted two- to
three-fold by Hank's medium into 6-8 doses.
Tumour take frequency was observed once a
week for 80 days (Urano and Suit, 1971).
(c) LD50 assay was employed to determine
the toxicity of the agent to animals and to
evaluate the sensitizing effect of IA on
normal tissue. After giving graded doses of
IA or x-rays, animal death was observed for
30 or 4 days respectively.
Calculation of TCD50, TD50 and LD50
was made by logit analysis on the basis of
tumour control, tumour take and mortality
frequency in each observation period re-
spectively. In all the experiments animals
were arranged randomly in groups before
giving treatments. Approximately 40-60
animals were used for each assay.
Testagent.-Iodoacetamide waspurchased
from Nakarai Chemical Co., Kyoto. A given
amount of the agent was solved in balanced
salt solution so as to inject 0 01 ml/g body
weight. Administration of the agent was
made intraperitoneally.
RESULTS
Toxicity to mice
In order to detect a pertinent drug
dose which animals can tolerate, LD50/30
to mice of IA was studied. Results are
presented in Table I. All the animals
receiving a dose larger than 67 mg/kg
TABLE I.-Mortality Frequency of C3H/He
Mice Given a Single Injection of Iodo-
acetamide
Dose of IA
injected
(mg/kg)
100
67
60
45
40
35
30
20
MIortality frequency on
post-treatment
Day 1 Day 3 Day 30
7/7 7/7 7/7
8/8 8/8 8/8
7/8 8/8 8/8
5/15 15/15 15/15
4/8 8/8 8/8
0/8 3/8 3/8
0/8 0/8 0/8
0/8 0/8 0/8
died within 24 hours after injection. At
the intermediate dose levels, i.e., 45-30
mg/kg, mice died within 72 hours.
Animals were able to tolerate a dose less
than 30 mg/kg. After 72 hours no animal
death was observed at any dose levels
tested. Therefore, LD50/30 was equal to
LD50/3 and was 35-5 mg/kg.
Cytotoxicity to tumour cells
Four concomitant TD50 assays were
made to examine the lethal effect of IA
on tumour cells. Animals in an assay
group received a fixed amount of IA,
i.e., one of the test doses, at 24 hours
after transplantation when the transplant
was expected to have formed an actively
proliferating microcolony. As shown in
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TABLE II.-Cytotoxic Effect of Jodoacetamide on C(3H/He Mouse Mammary
Carcinoma Cells
Dose of IA injected
(mg/kg)
6
12
18
TD50 in 80 days (95% confidence limits)
2-8 x 103 (1 2 x 103-6-9 x 103)
8-4 x 103 (9-6 x 102-7 4 x 104)
4-2 x 103 (2 0 x 103-8-6 x 103)
4 0 x 103 (1-7 x 103 92 x 103)
TABLE III.-TCD50 of C3H/He Mouse Mammary Carcinomna Pr-eviously
Treated or Untreated with Iodoacetamide
Dose of IA injected(
(mg/kg)
0
1.5
0
10 10
Condition at Number of
x-irradiation treatments
Hypoxia 1
95% 02 + 50 CO., 1
Hypoxia 1
Hypoxia 1
Hypoxia
Hypoxia
Air
Air
3
3
3
3
TCD50 in 120) days (ra(l)
(9.5 0 coinfidence limits)
6090 (5760-6440)
5420 (5240-5600)
6070 (5850-5730)
5430 (5150-5730)
7010 (6890-7130)
6880 (6750-7020)
6400 (5760-7120)
6480 (6330-6640)
Table II, all TD50 values were within
experimental errors. That means that
IA did not inactivate tumour cells at the
dose levels tested.
Sensitization studies
In the first series of experiments,
irradiation was given in a single dose at
30 min after administration of IA.
As presented in Table III, TCD50 (15 mg/
kg IA, hypoxia)* was significantly less
than TCD50 (without IA, hypoxia), while
TCD50 (5 mg/kg IA, hypoxia) was equiva-
lent to the control value. The ratio of
TCD50 (without IA, hypoxia) to TCD50
(15 mg/kg IA, hypoxia) was 1P12, indi-
cating that some fraction of hypoxic
tumour cells were sensitized by the agent.
The second series of studies was
performed with 3 fractionated doses.
The first and second doses were con-
ditioned at 1000 rad and the third dose
was varied in dose level in each
assay. The amount of IA was reduced
to 10 mg/kg, since 3 injections each of
15 mg/kg would be too toxic to the host.
As shown in the lower half of Table III,
the TCD50 (non-treated, air) was signifi-
cantly less than the TCD50 (non-treated,
hypoxia), while the sensitizing effect of
the agent was not observed in tumours
irradiated under air nor under hypoxic
condition.
Effect of IA on LD50/4
The LD50/4 after whole body irradia-
tion of mice might reflect an x-ray
response of intestinal crypt cells. The
whole body irradiation was given 30
min after administration of 15 mg/kg
IA. Animal death was observed mainly
between 3 and 4 days after irradiation,
with symptoms of severe diarrhoea. The
LD50/4 for mice treated or untreated
with IA was 870 or 980 rad respectively.
The ratio of LD50/4 of untreated to that
of IA treated mice was 1-13, which was
similar to the ratio of TCD50 (without
IA, hypoxia) to TCD50 (15 mg/kg IA,
hlypoxia).
DISCUSSION
Among the thiol-binding agents, IA is
well documented as one of the most
powerful radiosensitizers in the inactiva-
tion of bacteria (Dean and Alexander,
1965; Moroson and Tenney, 1968) and in
30-day mortality of mice (Moroson and
* TCD50 oftumotors received 15 mg/kg anid thein irradiated uncler hypoxic coinclitionls.
192SENSITIZATION BY IODOACETAMIDE 193
Spielman, 1966). While the magnitude of
this effect varied for each strain of
bacteria, it was demonstrated in this
study that the agent similarly sensitized
both hypoxic tumour cells and aerobic
normal cells. The tumour cell fraction
sensitized by IA was calculated from a
result that TCD50 (without IA, hypoxia)
to TCD50 (15 mg/kg IA, hypoxia) was
1-12, indicating that approximately 85%
oftumour cells were sensitized ifirradiated
under hypoxic conditions using the model
described by Suit, Shalek and Wette
(1965). This calculation was also based
on an assumption that the radiosensitivity
of our tumour cells could be represented
by an extrapolation number of 8 and D0
(dose to reduce survival from 1 to 1/e
in the exponential portion of the survival
curve) of 390 rad (unpublished data).
It has been estimated that this
tumour contains 20-25% hypoxic cells
(Suit and Maeda, 1967). The present
results indicate that approximately 85%
of these original hypoxic cells were
sensitized. Also, the fact that the TCD50
(15 mg/kg IA, hypoxia) was similar to the
TCD50 (without IA, oxygen) suggests that
15 mg/kg IA had a similar sensitizing
effect to oxygen. However, the IA was
more toxic (40%o of LD50/30) to the
animals than oxygen. Also, with frac-
tionated doses, a sensitizing effect of IA
is not observed in tumours irradiated
under air, nor under hypoxic conditions.
Therefore, IA is not considered to be of
therapeutic advantage in this system.
This work is partially supported by a
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